ArticleFrontiers in public health2026
Comprehensive evaluation of cardiovascular risk control in a large national cohort: insights from over 1 million participants in a cardiovascular prevention program.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SIRT1 in Cardiac Diseases: Molecular Mechanisms, Therapeutic Potential, and Future Directions.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiovascular diseases (CVDs) remain the leading cause of mortality in Europe, driven by a persistently high prevalence of modifiable risk factors. The aim of this study is to asse Methods: This cross-sectional study included 1,187,168 adults (718,528 women; 468,640 men) screened as part of Polish Cardiovascular Prevention Program. Evaluated risk factors were hypertension, hypercholesterolemia, elevated fasting glucose, tobacco use, low physical activity, overweight, and obesity. Analyses were stratified by age, sex, and year of participation. Linear and polynomial regression models were used to describe age-related patterns and short-term changes observed over the study period. Results: Overweight (46.9-47.0% vs. 33.3-34.0%; Conclusion: In a large cohort without cardiovascular disease, we identified alarmingly high levels of modifiable risk factors, with significant age and sex disparities. These findings highlight the urgent need for targeted, sex- and age-specific strategies to reduce cardiovascular risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.